Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
Proc Natl Acad Sci U S A
1999 Apr 27;969:4797-802. doi: 10.1073/pnas.96.9.4797.
Show Gene links
Show Anatomy links
A cyclin-dependent kinase inhibitor inducing cancer cell differentiation: biochemical identification using Xenopus egg extracts.
Rosania GR
,
Merlie J
,
Gray N
,
Chang YT
,
Schultz PG
,
Heald R
.
???displayArticle.abstract???
Cellular differentiation is a complex process involving growth arrest, exit from the cell cycle, and expression of differentiated cell-type-specific functions. To identify small molecules promoting this process, a chemical library was screened by using a myeloid leukemic cell line that retained the potential to differentiate in culture. In the presence of a purine derivative, aminopurvalanol (AP), cells acquired phenotypic characteristics of differentiated macrophages and became arrested in the cell cycle with a 4N DNA content. AP also inhibited mitosis in Xenopus egg extracts, suggesting that it acted on an evolutionarily conserved cell cycle regulatory pathway. Affinity chromatography and biochemical reconstitution experiments with Xenopus egg extracts identified cyclin-dependent kinase (CDK) 1-cyclin B as a target of the compound. Although AP potently inhibited immunoprecipitates of both human CDK1 and CDK2 from human leukemic cell extracts, our results indicate that the compound preferentially targets the G2/M-phase transition in vivo.
Baghdassarian,
Cyclin-dependent kinase inhibitors (CKIs) and hematological malignancies.
1996, Pubmed
Baghdassarian,
Cyclin-dependent kinase inhibitors (CKIs) and hematological malignancies.
1996,
Pubmed
Breitman,
Induction of differentiation of the human promyelocytic leukemia cell line (HL-60) by retinoic acid.
1980,
Pubmed
Felix,
A post-ribosomal supernatant from activated Xenopus eggs that displays post-translationally regulated oscillation of its cdc2+ mitotic kinase activity.
1989,
Pubmed
,
Xenbase
Gong,
Unscheduled expression of cyclin B1 and cyclin E in several leukemic and solid tumor cell lines.
1994,
Pubmed
Gorczyca,
Detection of DNA strand breaks in individual apoptotic cells by the in situ terminal deoxynucleotidyl transferase and nick translation assays.
1993,
Pubmed
Gray,
Exploiting chemical libraries, structure, and genomics in the search for kinase inhibitors.
1998,
Pubmed
Guadagno,
Cdk2 kinase is required for entry into mitosis as a positive regulator of Cdc2-cyclin B kinase activity.
1996,
Pubmed
,
Xenbase
Hansen,
Re-examination and further development of a precise and rapid dye method for measuring cell growth/cell kill.
1989,
Pubmed
Harris,
Human leukemic models of myelomonocytic development: a review of the HL-60 and U937 cell lines.
1985,
Pubmed
Heald,
Self-organization of microtubules into bipolar spindles around artificial chromosomes in Xenopus egg extracts.
1996,
Pubmed
,
Xenbase
Hunter,
Cyclins and cancer. II: Cyclin D and CDK inhibitors come of age.
1994,
Pubmed
Johnson,
Sequential protein kinase reactions controlling cell growth and differentiation.
1994,
Pubmed
Lew,
Isolation of three novel human cyclins by rescue of G1 cyclin (Cln) function in yeast.
1991,
Pubmed
Liu,
Transcriptional activation of the Cdk inhibitor p21 by vitamin D3 leads to the induced differentiation of the myelomonocytic cell line U937.
1996,
Pubmed
Love,
Vitamin A, differentiation and cancer.
1994,
Pubmed
Meijer,
Chemical inhibitors of cyclin-dependent kinases.
1997,
Pubmed
Murray,
Cell cycle extracts.
1991,
Pubmed
Murray,
The role of cyclin synthesis and degradation in the control of maturation promoting factor activity.
1989,
Pubmed
,
Xenbase
Murray,
Cyclin synthesis drives the early embryonic cell cycle.
1989,
Pubmed
,
Xenbase
Nigg,
Cyclin-dependent protein kinases: key regulators of the eukaryotic cell cycle.
1995,
Pubmed
Robles,
Site-directed mutant p21 proteins defective in both inhibition of E2F-regulated transcription and disruption of E2F-p130-cyclin-cdk2 complexes.
1998,
Pubmed
Rosenblatt,
Human cyclin-dependent kinase 2 is activated during the S and G2 phases of the cell cycle and associates with cyclin A.
1992,
Pubmed
Sawin,
Mitotic spindle assembly by two different pathways in vitro.
1991,
Pubmed
,
Xenbase
Schutte,
The effect of the cyclin-dependent kinase inhibitor olomoucine on cell cycle kinetics.
1997,
Pubmed
Sidle,
Activity of the retinoblastoma family proteins, pRB, p107, and p130, during cellular proliferation and differentiation.
1996,
Pubmed
Smythe,
Systems for the study of nuclear assembly, DNA replication, and nuclear breakdown in Xenopus laevis egg extracts.
1991,
Pubmed
,
Xenbase
Stern,
A quantitative model for the cdc2 control of S phase and mitosis in fission yeast.
1996,
Pubmed
,
Xenbase
Sundström,
Establishment and characterization of a human histiocytic lymphoma cell line (U-937).
1976,
Pubmed
Tallman,
All-trans-retinoic acid in acute promyelocytic leukemia.
1997,
Pubmed
Wilhelm,
Purification of recombinant cyclin B1/cdc2 kinase from Xenopus egg extracts.
1997,
Pubmed
,
Xenbase